|4Feb 24, 6:48 PM ET

GUY GEOFFREY W DR 4

4 · GW PHARMACEUTICALS PLC · Filed Feb 24, 2021

Insider Transaction Report

Form 4
Period: 2021-02-22
Transactions
  • Award

    Share Options

    2021-02-22+131,712131,712 total
    Exercise: $0.00From: 2024-02-22Exp: 2031-02-22Ordinary Shares (131,712 underlying)
  • Award

    Share Options

    2021-02-22+82,32082,320 total
    Exercise: $0.00Exp: 2031-02-22Ordinary Shares (82,320 underlying)
Footnotes (5)
  • [F1]Granted pursuant to the Issuer's Long-Term Incentive Plan. These share options will vest on February 22, 2024 if certain performance conditions are satisfied.
  • [F2]Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.41 U.S. Dollars as of February 22, 2021.
  • [F3]Granted pursuant to the Issuer's Long-Term Incentive Plan
  • [F4]These share options will vest in four equal annual installments beginning on February 22, 2022.
  • [F5]Subject to accelerated vesting in connection with the closing of the transactions contemplated by the Transaction Agreement, dated as of February 3, 2021, by and among Jazz Pharmaceuticals UK Holdings Limited, Jazz Pharmaceuticals Public Limited Company and GW Pharmaceuticals plc.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION